Citius Oncology, Inc. Capital Reinvestment Ratio
Citius Oncology, Inc. capital reinvestment ratio. Citius Oncology, Inc. (CTOR) has a Capital Reinvestment Ratio of 0.00x as of September 2024, meaning it reinvests 0% of its operating cash flow ($900.29K) in capital expenditures ($0.46). Check CTOR cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Citius Oncology, Inc. (2024–2024)
Capital reinvestment ratio of Citius Oncology, Inc. from 2024 to 2024. This chart tracks Citius Oncology, Inc.'s Capital Reinvestment Ratio across 1 annual periods. Also explore how fast is Citius Oncology, Inc. growing its equity to track the company's year-over-year net asset growth rate.
Citius Oncology, Inc. Capital Reinvestment Ratio by Year (2024–2024)
Citius Oncology, Inc. capital reinvestment ratio by year from 2024 to 2024. For the full cash flow conversion analysis, see CTOR cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | $126.35K | $4.00 | — |